drugset / Trial / NCT07696520
Bepirovirsen Liver Biopsy Study
Phase 2
Not yet recruiting
30 enrolled
National University Health System, Singapore
A*Star · collabNational University of Singapore · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Bepirovirsen Liver Biopsy study is a single centre open label phase II study to examine the antiviral and immunological effects of bepirovirsen in CHB patients both treated and untreated with HBsAg\<1000 IU/ml
Timeline
- Start
- 2026-07-01
- Primary completion
- 2027-12-30
- Completion
- 2028-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bepirovirsen | Antisense oligonucleotide | — | — |